搜尋結果
Moderna, Inc. (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response .
In June 2020, Singapore signed a pre-purchase agreement for Moderna, reportedly paying a price premium in order to secure early stock of vaccines, although the government declined to provide the actual price and quantity, citing commercial sensitivities and
其他人也問了
What does Moderna stand for?
How did Moderna become a public company?
How much does Moderna cost?
Who owns Moderna biotech?
- Personal Life
- Academic Career and Inventions
- Business Career
- Philanthropy
- Politics
- Recognition
Afeyan was born to Armenian parents in Beirut, Lebanon in 1962. His grandfather survived the Armenian genocide. Talking about his background, Afeyan said: "One of the only unfortunate advantages Armenians have had by having gone through a genocide and having spread around the world is that we do have an experience of escaping and of immigrating and...
Afeyan has authored numerous scientific papers. He has patented over 100 inventions. Between 2000 and 2016 he was a senior lecturer at the MIT Sloan School of Management and is currently (as of 2020) a lecturer at Harvard Business School. In July 2022, Afeyan was conferred with an honorary doctorate degree from Yerevan State University.
Afeyan started his first biotechnology company in 1987, just a few days before Black Monday, and founded or co-founded five more companies within ten years. By 2020 Afeyan had co-founded and developed 41 start-ups.In total, he co-founded or helped build over 50 life science and technology startups. Afeyan is the founder and CEO of Flagship Pioneeri...
Afeyan sits on the boards of the MIT Corporation, the Boston Symphony Orchestra, and the Armenian General Benevolent Union(AGBU). Afeyan has worked closely with other prominent Armenian diaspora philanthropists, most notably Ruben Vardanyan on projects related to Armenia. Afeyan had partnered with Vardanyan to establish Initiatives for Development ...
In October 2016 Afeyan joined other prominent Armenians on calling the government of Armenia to adopt "new development strategies based on inclusiveness and collective action" and to create "an opportunity for the Armenian world to pivot toward a future of prosperity, to transform the post-Soviet Armenian Republic into a vibrant, modern, secure, pe...
Armenian Prime Minister's Commemorative Medal for Patriotic Activities (2012)Technology Pioneer award, World Economic Forum(2012)Medal of Services to the Motherland (2014) by President of Armenia Serzh SargsyanSM-102 is a synthetic amino lipid which is used in combination with other lipids to form lipid nanoparticles. [1] . These are used for the delivery of mRNA-based vaccines, [2] [3] [4] and in particular SM-102 forms part of the drug delivery system for the Moderna COVID-19 vaccine. [5] [6] [7]
In late 2010, Flagship formed Moderna, which focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA) technology, and which is famous for its COVID-19 vaccine.
Although Slaoui resigned from the Moderna board when named to head Warp Speed, his share value in Moderna stock increased by $3 million in one day when Moderna announced an advance in vaccine clinical research.
In April 2020, with the Moderna share price rising on news of imminent phase 2 human trials for its potential COVID-19 vaccine, Bancel's stake of about 9% became worth over $1 billion. He lives in Boston , Massachusetts.
